EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Characterization and Anti-bacterial Screening of Fe(II) Mixed Ligand Complex of Ofloxacin with Ascorbic Acid

Ugochukwu Onyenze, Ifeanyi Otuokere, Joy Emmanuel

European Journal of Scientific Research and Reviews · 2024

DOI: 10.5455/ejsrr.20240607014716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Scientific Research and Reviews, 2024. Verfasst von Ugochukwu Onyenze und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Mixed ligand complexes play a major role in biological processes by binding with small molecules and activating the enzymes for nuclease activity. This study is aimed at synthesizing, characterizing, and the antibacterial studies of 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H- Pyridol[1,2,3,-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin) and ascorbic acid metal complex.

Methods

Iron(II) mixed ligand complex of ofloxacin and ascorbic acid was synthesized using the reflux method. The resulting complex, [Fe(Ofl)(Asc)] was characterized by its color, solubility, melting point, FTIR, electronic spectra, 1H NMR, and 13C NMR spectroscopy.

Results

The dark gray color and the high melting point of the Fe(II) mixed ligand complex indicate that complexation occurred. From the electronic data, octahedral geometry was suggested for the complex. According to the FTIR data for both ofloxacin and ascorbic acid, the two ligands functioned as tridentate ligands, coordinating to the metal through the oxygen atoms of the two carbonyl groups, hydroxyl group in the case of ofloxacin and carbonyl, and the enolic C-2 and C-3 hydroxyl groups in the case of ascorbic acid. The antibacterial activities of the prepared mixed ligand complex were evaluated against Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, and Escherichia coli. The result of the antibacterial activities of [Fe(Ofl)(Asc)] shows that the mixed ligand complex has higher antibacterial activities compared to the parent drug. In the mixed complex, the Fe(II) complex shows the highest inhibition against the four species.

Conclusion

The complex exhibited more antimicrobial activity than the participating ligands. The results reported from this study will therefore aid in the development of more effective drugs that are effective against resistant microorganisms.

Zitieren

APA

Onyenze, U., Otuokere, I., & Emmanuel, J. (2024). Synthesis, Characterization and Anti-bacterial Screening of Fe(II) Mixed Ligand Complex of Ofloxacin with Ascorbic Acid. European Journal of Scientific Research and Reviews. https://doi.org/10.5455/ejsrr.20240607014716

Vancouver

Onyenze U, Otuokere I, Emmanuel J. Synthesis, Characterization and Anti-bacterial Screening of Fe(II) Mixed Ligand Complex of Ofloxacin with Ascorbic Acid. European Journal of Scientific Research and Reviews. 2024. doi:10.5455/ejsrr.20240607014716

BibTeX
@article{Onyenze2024,
  author = {Onyenze, Ugochukwu and Otuokere, Ifeanyi and Emmanuel, Joy},
  title = {Synthesis, Characterization and Anti-bacterial Screening of Fe(II) Mixed Ligand Complex of Ofloxacin with Ascorbic Acid},
  journal = {European Journal of Scientific Research and Reviews},
  year = {2024},
  doi = {10.5455/ejsrr.20240607014716}
}
Kostenlos starten →